These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29432284)

  • 1. β-Blockers in myocardial infarction and coronary artery disease with a preserved ejection fraction: recommendations, mechanisms, and concerns.
    Nambiar L; Meyer M
    Coron Artery Dis; 2018 May; 29(3):262-270. PubMed ID: 29432284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.
    Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K
    Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers do not provide survival benefit in a population with angiographic coronary artery disease without myocardial infarction or reduced ejection fraction: A meta-analysis.
    Jaradat M; Shetty K; Hasan M; Malik AO; Shawo A; Ahsan C; Yoo JW
    Int J Cardiol; 2016 Nov; 223():976-980. PubMed ID: 27591695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.
    Peyracchia M; Errigo D; Raposeiras Rubin S; Conrotto F; DiNicolantonio JJ; Omedè P; Rettegno S; Iannaccone M; Moretti C; D'Amico M; Gaita F; D'Ascenzo F
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):337-343. PubMed ID: 29877974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers in the management of coronary artery disease: are we on the verge of a new paradigm shift?
    Elgendy IY; Mahmoud A; Conti CR
    Recent Pat Cardiovasc Drug Discov; 2014; 9(1):11-21. PubMed ID: 25174339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study.
    Wen XS; Luo R; Liu J; Duan Q; Qin S; Xiao J; Zhang DY
    BMC Cardiovasc Disord; 2022 Apr; 22(1):193. PubMed ID: 35473676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5).
    Joseph P; Swedberg K; Leong DP; Yusuf S
    J Am Coll Cardiol; 2019 Aug; 74(5):672-682. PubMed ID: 31370960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction.
    Xu X; Wang DW
    Int J Cardiol Heart Vasc; 2020 Feb; 26():100451. PubMed ID: 31886405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current use of beta-blockers in patients with coronary artery disease.
    Andreasen C; Andersson C
    Trends Cardiovasc Med; 2018 Aug; 28(6):382-389. PubMed ID: 29373178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular arrhythmias: antiadrenergic therapy for the patient with coronary artery disease.
    Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S23-31. PubMed ID: 15965569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for administering beta-blocker therapy to patients undergoing coronary artery bypass surgery: a systematic review.
    Thaper A; Kulik A
    Expert Opin Drug Saf; 2018 Aug; 17(8):805-813. PubMed ID: 30037300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with beta-blockers in patients with acute coronary syndrome].
    Nozawa T; Inoue H
    Nihon Rinsho; 1998 Oct; 56(10):2612-6. PubMed ID: 9796327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
    Steg PG; Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox KM;
    PLoS One; 2012; 7(5):e36284. PubMed ID: 22570699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic blockade in the prevention of myocardial infarction: a new theory.
    Frishman WH; Chang CM
    J Hypertens Suppl; 1991 Dec; 9(7):S31-4. PubMed ID: 1686459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction.
    Lee SH; Yoon SB; Cho JR; Choi S; Jung JH; Lee N
    Angiology; 2008 Dec-2009 Jan; 59(6):676-81. PubMed ID: 18388053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.